The Effect of Vitamin A, Retinoids and Retinoid Receptors on the Hypothalamic-Pituitary-Thyroid Axis

  • Bryan R. Haugen
Part of the Endocrine Updates book series (ENDO, volume 22)

Abstract

The effects of vitamin A on thyroid hormone production and action have been known for many years. In the 1940s, Simkins demonstrated that patients with hyperthyroidism, were successfully treated with high dose of vitamin A (1) . When treated with vitamin A, these hyperthyroid patients had decreased symptoms of hyperthyroidism as well as decreased metabolic rate. Shadu and Brody studied this effect in euthyroid rats which were fed 30,000 IU of vitamin A per day for 7 days (2). The vitamin A fed rats had a 10% decrease in oxygen consumption and interestingly were found to have a 35% decrease in thyroid weight. The authors hypothesized that vitamin A suppresses pituitary thyrotropic hormone secretion thereby decreasing thyroid hormone production and oxygen consumption. This was the first suggestion that large doses of vitamin A may be affecting thyroid hormone production and function through a central mechanism. Morley and colleagues performed complementary experiments by feeding rats diets that were deficient in vitamin A and pair feeding animals with the same diet plus a supplement of 1,000 IU of vitamin A to normalize the vitamin A level (3). The animals were fed the vitamin A deficient diet until they had early signs of vitamin A deficiency, which included eye lesions and slight weight decrease.

Keywords

Iodine Adenoma Hypothyroidism Acne Palmitate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Simkins, S. 1947. Use of massive doses of vitamin A in the treatment of hyperthyroidsim. Journal of Clinical Endocrinology and Metabolism 7:574–585.PubMedCrossRefGoogle Scholar
  2. 2.
    Shadu, D.P. and Brody, S. 1947. Excess vitamin A ingestion, thyroid size and energy metabolism. American Journal of Physiology 149:400–404.Google Scholar
  3. 3.
    Morley, J.E., Damassa, D. A., Gordon, J., Pekary, A.E., and Hershman, J.M. 1978. Thyroid function and vitamin A deficiency. Life Sciences 22:1901–1906.PubMedCrossRefGoogle Scholar
  4. 4.
    Morley, J.E., Melmed, S., Reed, A., Kasson, B.G., Levin, S.R., Pekary, A.E., and Hershman, J.M. 1980. Effect of vitamin A on the hypothalamo-pituitary-thyroid axis. Am.J.Physiol 238:E174–E179.PubMedGoogle Scholar
  5. 5.
    Garcin, H. and Higueret, P. 1979. Vitamin A-deficiency and thyrotropin secretion in the rat. J.Physiol (Paris) 75:887–890.Google Scholar
  6. 6.
    Ravaglia, G., Forti, P., Maioli, F., Nesi, B., Pratelli, L., Savarino, L., Cucinotta, D., and Cavalli, G. 2000. Blood micronutrient and thyroid hormone concentrations in the oldest-old. J.Clin.Endocrinol.Metab 85:2260–2265.PubMedCrossRefGoogle Scholar
  7. 7.
    Ceresini, G., Rebecchi, I., Morganti, S., Maggio, M., Solerte, S.B., Corcione, L., Izzo, S., Mecocci, P., and Valenti, G. 2002. Effects of vitamin A administration on serum thyrotropin concentrations in healthy human subjects. Metabolism 51:691–694.PubMedCrossRefGoogle Scholar
  8. 8.
    Lotan, R., Xu, X.C., Lippman, S.M., Ro, J.Y., Lee, J.S., Lee, J.J., and Hong, W.K. 1995. Suppression of retinoic acid receptorbeta in premalignant oral lesions and its up-regulation by isotretinoin. N.Engl.J.Med. 332:1405–1410.PubMedCrossRefGoogle Scholar
  9. 9.
    Evans, T.R. and Kaye, S.B. 1999. Retinoids: present role and future potential. Br. J. Cancer 80:1–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Schmutzler, C. and Kohrle, J. 2000. Retinoic acid redifferentiation therapy for thyroid cancer. Thyroid 10:393–406.PubMedCrossRefGoogle Scholar
  11. 11.
    Marsden, J.R., Trinick, T.R., Laker, M.F., and Shuster, S. 1984. Effects of isotretinoin on serum lipids and lipoproteins, liver and thyroid function. Clin.Chim.Acta 143:243–251.PubMedCrossRefGoogle Scholar
  12. 12.
    O’Leary, T.J., Simo, I.E., Kanigsberg, N.D., and Ooi, T.C. 1986. Lack of effect of isotretinoin on thyroid-function tests. Clin.Chem. 32:913–914.PubMedGoogle Scholar
  13. 13.
    Coya, R., Carro, E., Mallo, F., and Dieguez, C. 1997. Retinoic acid inhibits in vivo thyroid-stimulating hormone secretion. Life Sci. 60:L–50.CrossRefGoogle Scholar
  14. 14.
    Blaner, W.S. 2001. Cellular metabolism and actions of 13-cis-retinoic acid. J.Am.Acad.Dermatol. 45:S129–S135.PubMedCrossRefGoogle Scholar
  15. 15.
    Baura, A.B. and Furr, H.C. 1998. Properties of retinoids: structure, handling and preparation. In Retinoid protocols. C.P.F. Redfern, editor. Humana Press, Totowa. 3–28.CrossRefGoogle Scholar
  16. 16.
    Breen, J.J., Matsuura, T., Ross, A.C., and Gurr, J.A. 1995. Regulation of thyroid-stimulating hormone beta-subunit and growth hormone messenger ribonucleic acid levels in the rat: effect of vitamin A status. Endocrinology 136:543–549.PubMedCrossRefGoogle Scholar
  17. 17.
    Breen, J.J., Hickok, N.J., and Gurr, J.A. 1997. The rat TSH beta gene contains distinct response elements for regulation by retinoids and thyroid hormone. Molecular and Cellular Endocrinology 131:137–146.PubMedCrossRefGoogle Scholar
  18. 18.
    Haugen, B.R., Brown, N.S., Wood, W.M., Gordon, D.F., and Ridgway, E.C. 1997. The thyrotrope-restricted isoform of the retinoid X receptor (gamma 1) mediates 9-cis retinoic acid suppression of thyrotropin beta promoter activity. Molecular Endocrinology 11:481–489.PubMedCrossRefGoogle Scholar
  19. 19.
    Mangelsdorf, D.J., Borgmeyer, U., Heyman, R.A., Zhou, J.Y., Ong, E.S., Oro, A.E., Kakizuka, A., and Evans, R.M. 1992. Characterization of the three RXR genes that mediate the action of 9-cis retinoic acid. Genes and Development 6:329–344.PubMedCrossRefGoogle Scholar
  20. 20.
    Sugawara, A., Yen, P.M., Qi, Y., Lechan, R.M., and Chin, W.W. 1995. Isoform-specific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland. Endocrinology 136:1766–1774.PubMedCrossRefGoogle Scholar
  21. 21.
    Sanno, N., Sugawara, A., Teramoto, A., Abe, Y., Yen, P.M., Chin, W.W., and Osamura, R.Y. 1997. Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas. Neuroendocrinology 65:299–306.PubMedCrossRefGoogle Scholar
  22. 22.
    Krezel, W., Dupe, V., Mark, M., Dierich, A., Kastner, P., and Chambon, P. 1996. RXR gamma null mice are apparently normal and compound RXRa +/-, RXRb -/-, RXRg — /- mutant mice are viable. Proceedings of the National Academy of Sciences of the United States of America 93:9010–9014.PubMedGoogle Scholar
  23. 23.
    Brown, N.S., Smart, A., Sharma, V., Brinkmeier, M.L., Greenlee, L., Camper, S.A., Jensen, D.R., Eckel, R.H., Krezel, W., Chambon, P. et al. 2000. Thyroid hormone resistance and increased metabolic rate in the RXR- gamma-deficient mouse. J. Clin.Invest 106:73–79.PubMedCrossRefGoogle Scholar
  24. 24.
    Sherman, S.I., Gopal, J., Haugen, B.R., Chiu, A.C., Whaley, K.N.P., and Duvic, M. 1999. Central hypothyroidism associated with retinoid X receptor selective ligands. New England Journal of Medicine 340:1075–1079.PubMedCrossRefGoogle Scholar
  25. 25.
    Alarid, E.T., Windle, J.J., Whyte, D.B., and Mellon, P.L. 1996. Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development 122:3319–3329.PubMedGoogle Scholar
  26. 26.
    Reutrakul, S., Sadow, P.M., Pannain, S., Pohlenz, J., Carvalho, G.A., Macchia, P.E., Weiss, R.E., and Refetoff, S. 2000. Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes. J. Clin.Endocrinol.Metab 85:3609–3617.PubMedCrossRefGoogle Scholar
  27. 27.
    Macchia, P.E., Jiang, P., Yuan, Y.D., Chandarardna, R.A., Weiss, R.E., Chassande, O., Samarut, J., Refetoff, S., and Burant, C.F. 2002. RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor. Am.J.Physiol Endocrinol.Metab 283:E326–E331.PubMedGoogle Scholar
  28. 28.
    Liu, S., Ogilvie, K.M., Klausing, K., Lawson, M.A., Jolley, D., Li, D., Bilakovics, J., Pascual, B., Hein, N., Urcan, M. et al. 2002. Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat. Endocrinology 143:2880–2885.PubMedCrossRefGoogle Scholar
  29. 29.
    Jones, K.E., Yaffe, B.M., and Chin, W.W. 1993. Regulation of the thyroid hormone receptor beta-2 mRNA levels by retinoic acid. Molecular and Cellular Endocrinology 91:113–118.PubMedCrossRefGoogle Scholar
  30. 30.
    Satoh, T., Ishizuka, T., Monden, T., Shibusawa, N., Hashida, T., Kishi, M., Yamada, M., and Mori, M. 1999. Regulation of the mouse preprothyrotropin-releasing hormone gene by retinoic acid receptor. Endocrinology 140:5004–5013.PubMedCrossRefGoogle Scholar
  31. 31.
    Arai, M., Tsushima, T., Isozaki, O., Shizume, K., Emoto, N., Demura, H., Miyakawa, M., and Onoda, N. 1991. Effects of retinoids on iodine metabolism, thyroid peroxidase gene expression, and deoxyribonucleic acid synthesis in porcine thyroid cells in culture. Endocrinology 129:2827–2833.PubMedCrossRefGoogle Scholar
  32. 32.
    Esfandiari, A., Gagelin, C., Gavaret, J.M., Pavelka, S., Lennon, A.M., Pierre, M., and Courtin, F. 1994. Induction of type III-deiodinase activity in astroglial cells by retinoids. Glia 11:255–261.PubMedCrossRefGoogle Scholar
  33. 33.
    Dabon-Almirante, C.L., Damle, S., Wdaler, S., and Hupart, K. 1999. Related case report: in vivo suppression of thyrotropin by 9–cis retinoic acid. Cancer J.Sci.Am 5:171–173.PubMedGoogle Scholar
  34. 34.
    Miller, V.A., Benedetti, F.M., Rigas, J.R., Verret, A.L., Pfister, D.G., Straus, D., Kris, M.G., Crisp, M., Heyman, R., Loewen, G.R. et al. 1997. Initial clinical trial of a selective retinoid X receptor ligand, LGD 1069. Journal of Clinical Oncology 15:790–795.PubMedGoogle Scholar
  35. 35.
    Duvic, M., Martin, A.G., Kim, Y., Olsen, E., Wood, G.S., Crowley, C.A., and Yocum, R.C. 2001. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch.Dermatol. 137:581–593.PubMedGoogle Scholar
  36. 36.
    Haugen, B.R., Hays, W., McGuirk, M., and Sharma, V. 2002. A combination of a thiazolidendione and a retinoid synergistically inhibits thyroid cancer cell proliferation. 74th Annual meeting of the American Thyroid Association 178 (Abstr.)Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Bryan R. Haugen
    • 1
  1. 1.Division of Endocrinology, Department of Medicine, University of Colorado Cancer CenterUniversity of Colorado Health Sciences CenterDenverUSA

Personalised recommendations